Literature DB >> 8027235

A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation.

A E Taylor1, R H Khoury, W F Crowley.   

Abstract

To determine whether the new immunometric (sandwich) assays for gonadotropins achieve the alleged improvements over RIAs, we compared 13 commercial kits for LH and FSH with our established and validated polyclonal RIAs. Although the kits claimed detection limits as low as 0.05 IU/L, when sensitivity was tested with a uniform hormone standard (the Second International Reference Preparation of human menopausal gonadotropin urinary standard) and the requirement that the limit must be determined from a detectable standard point rather than the variance around zero, only 4 kits surpassed the detectability achieved by the existing LH and FSH RIAs. Seven of the 10 LH kits tested displayed greater than 10% cross-reactivity with either the alpha- or LH beta-subunit. The relationship between the kit standard and the Second International Reference Preparation of human menopausal gonadotropin uniform standard in each kit was nonlinear, so that attempts to compare results between assays with simple multiplication factors are inaccurate. Only 2 assays were designed to eliminate a hook effect. The following conclusions were reached. 1) Most available gonadotropin immunometric assays do not yet offer features not already available in existing validated polyclonal research assays. 2) Conversion of data from one assay to another is not straightforward. 3) Many of the manufacturers' claims do not appear justified. 4) Determination of the detection limit and other immunometric assay characteristics requires standardization of criteria. We propose the following minimum criteria for validating gonadotropin immunometric assays: 1) a uniform definition of the detection limit based on the lowest distinguishable standard concentration, 2) determination of the standard concentration at which a hook occurs, 3) determination of cross-reactivity to subunits as well as intact gonadotropins, and 4) establishment of an adequate normative data base.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027235     DOI: 10.1210/jcem.79.1.8027235

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

2.  Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women.

Authors:  E E Marsh; N D Shaw; K M Klingman; T O Tiamfook-Morgan; M A Yialamas; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

3.  Urinary beta-luteinizing hormone and beta-follicle stimulating hormone immunoenzymometric assays for population research.

Authors:  Eleanor Brindle; Rebecca C Miller; Jane B Shofer; Nancy A Klein; Michael R Soules; Kathleen A O'Connor
Journal:  Clin Biochem       Date:  2006-09-01       Impact factor: 3.281

4.  Expanding the phenotype and genotype of female GnRH deficiency.

Authors:  Natalie D Shaw; Stephanie B Seminara; Corrine K Welt; Margaret G Au; Lacey Plummer; Virginia A Hughes; Andrew A Dwyer; Kathryn A Martin; Richard Quinton; Veronica Mericq; Paulina M Merino; James F Gusella; William F Crowley; Nelly Pitteloud; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

5.  Serum concentrations of follicle stimulating hormone and luteinizing hormone in normal girls and boys during prepuberty and at early puberty.

Authors:  A Belgorosky; S Chahin; E Chaler; M Maceiras; M A Rivarola
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

6.  Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.

Authors:  R L Habiby; P Boepple; L Nachtigall; P M Sluss; W F Crowley; J L Jameson
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing.

Authors:  M S Opsahl; K L Blauer; S H Black; S R Lincoln; L Thorsell; R J Sherins
Journal:  J Assist Reprod Genet       Date:  2001-10       Impact factor: 3.412

8.  Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J A Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2015-06-30       Impact factor: 5.958

9.  Differential effects of aging on estrogen negative and positive feedback.

Authors:  N D Shaw; S S Srouji; S N Histed; J E Hall
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

Review 10.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.